| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Region | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CONS | PRCD | Aug 12, 2026 | HLNLN | Haleon US Capital LLC, Haleon PLC | A3 | BBB+ | - | $600 | Sr. Unsecured | 3.00 | - | Aug-29 | 4.625% | IGC | USOA | ||||
CONS | PRCD | Aug 12, 2026 | HLNLN | Haleon US Capital LLC, Haleon PLC | A3 | BBB+ | - | $600 | Sr. Unsecured | 5.00 | - | Aug-31 | 4.875% | IGC | USOA | ||||
CONS | PRCD | Aug 12, 2026 | HLNLN | Haleon US Capital LLC, Haleon PLC | A3 | BBB+ | - | $800 | Sr. Unsecured | 10.00 | - | Aug-36 | 5.375% | IGC | USOA | ||||
HLTH | PRCD | Sep 11, 2024 | HLNLN | Haleon UK Capital PLC | Baa1 | BBB+ | - | €750 | Sr. Unsecured | 4.00 | - | Sep-28 | 2.875% | IGC | EMEA | ||||
HLTH | PRCD | Sep 11, 2024 | HLNLN | Haleon UK Capital PLC | Baa1 | BBB+ | - | £300 | Sr. Unsecured | 9.00 | - | Sep-33 | 4.625% | IGC | EMEA | ||||
HLTH | PRCD | Mar 21, 2022 | HLNLN | GSK Consumer Healthcare Capital US LLC | Baa1 | BBB | - | $300 | Sr. Unsecured | 2.00 | 1.00 | Mar-24 | - | IGC | EMEA | ||||
HLTH | PRCD | Mar 21, 2022 | HLNLN | GSK Consumer Healthcare Capital US LLC | Baa1 | BBB | - | $700 | Sr. Unsecured | 2.00 | 1.00 | Mar-24 | 3.024% | IGC | EMEA | ||||
HLTH | PRCD | Mar 21, 2022 | HLNLN | GSK Consumer Healthcare Capital US LLC, GSK Consumer Healthcare Capital UK PLC | Baa1 | BBB | - | $1,750 | Sr. Unsecured | 3.00 | - | Mar-25 | 3.125% | IGC | EMEA | ||||
HLTH | PRCD | Mar 21, 2022 | HLNLN | GSK Consumer Healthcare Capital US LLC | Baa1 | BBB | - | $2,000 | Sr. Unsecured | 5.00 | - | Mar-27 | 3.375% | IGC | EMEA | ||||
HLTH | PRCD | Mar 21, 2022 | HLNLN | GSK Consumer Healthcare Capital US LLC | Baa1 | BBB | - | $1,000 | Sr. Unsecured | 7.00 | - | Mar-29 | 3.375% | IGC | EMEA |